2-201060065-G-C
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBS1BS2
The NM_001321623.1(HYCC2):c.-129+11545C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0077 in 130,400 control chromosomes in the GnomAD database, including 39 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.0077 ( 39 hom., cov: 21)
Consequence
HYCC2
NM_001321623.1 intron
NM_001321623.1 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.341
Publications
6 publications found
Genes affected
HYCC2 (HGNC:28593): (hyccin PI4KA lipid kinase complex subunit 2) Predicted to be involved in phosphatidylinositol phosphate biosynthetic process and protein localization to plasma membrane. Predicted to be located in cytosol. Predicted to be active in plasma membrane. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.95).
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0077 (1004/130400) while in subpopulation AFR AF = 0.0267 (951/35584). AF 95% confidence interval is 0.0253. There are 39 homozygotes in GnomAd4. There are 505 alleles in the male GnomAd4 subpopulation. Median coverage is 21. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 39 gene
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| HYCC2 | NM_001321623.1 | c.-129+11545C>G | intron_variant | Intron 1 of 12 | ENST00000681958.1 | NP_001308552.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| HYCC2 | ENST00000681958.1 | c.-129+11545C>G | intron_variant | Intron 1 of 12 | NM_001321623.1 | ENSP00000507218.1 |
Frequencies
GnomAD3 genomes AF: 0.00766 AC: 998AN: 130284Hom.: 39 Cov.: 21 show subpopulations
GnomAD3 genomes
AF:
AC:
998
AN:
130284
Hom.:
Cov.:
21
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.00770 AC: 1004AN: 130400Hom.: 39 Cov.: 21 AF XY: 0.00806 AC XY: 505AN XY: 62684 show subpopulations
GnomAD4 genome
AF:
AC:
1004
AN:
130400
Hom.:
Cov.:
21
AF XY:
AC XY:
505
AN XY:
62684
show subpopulations
African (AFR)
AF:
AC:
951
AN:
35584
American (AMR)
AF:
AC:
31
AN:
13098
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3140
East Asian (EAS)
AF:
AC:
1
AN:
3964
South Asian (SAS)
AF:
AC:
0
AN:
3602
European-Finnish (FIN)
AF:
AC:
0
AN:
7400
Middle Eastern (MID)
AF:
AC:
1
AN:
266
European-Non Finnish (NFE)
AF:
AC:
14
AN:
60734
Other (OTH)
AF:
AC:
6
AN:
1790
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.640
Heterozygous variant carriers
0
33
66
98
131
164
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.